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pBL1 is a Lactococcus lactis theta-replicating 10.9-kbp plasmid that encodes the synthetic machinery of the
bacteriocin Lcn972. In this work, the transcriptomes of exponentially growing L. lactis strains with and without
pBL1 were compared. A discrete response was observed, with a total of 10 genes showing significantly changed
expression. Upregulation of the lactococcal oligopeptide uptake (opp) system was observed, which was likely
linked to a higher nitrogen demand required for Lcn972 biosynthesis. Strikingly, celB, coding for the membrane
porter IIC of the cellobiose phosphoenolpyruvate-dependent phosphotransferase system (PTS), and the up-
stream gene llmg0186 were downregulated. Growth profiles for L. lactis strains MG1363, MG1363/pBL1, and
MG1363 celB grown in chemically defined medium (CDM) containing cellobiose confirmed slower growth of
MG1363/pBL1 and MG1363 celB, while no differences were observed with growth on glucose. The presence
of pBL1 shifted the fermentation products toward a mixed acid profile and promoted substantial changes in
intracellular pool sizes for glycolytic intermediates in cells growing on cellobiose as determined by high-
pressure liquid chromatography (HPLC) and nuclear magnetic resonance (NMR). Overall, these data support
the genetic evidence of a constriction in cellobiose uptake. Notably, several cell wall precursors accumulated,
while other UDP-activated sugar pools were lower, which could reflect rerouting of precursors toward the
production of structural or storage polysaccharides. Moreover, cells growing slowly on cellobiose and those
lacking celB were more tolerant to Lcn972 than cellobiose-adapted cells. Thus, downregulation of celB could
help to build up a response against the antimicrobial activity of Lcn972, enhancing self-immunity of the
producer cells.
Bacteriocins are ribosomally synthesized bacterial peptides
with antimicrobial activity. Their production is a widespread
trait in lactic acid bacteria (LAB). Bacteriocins form a rather
structurally diverse group encompassing posttranslationally
modified lantibiotics (class I), nonmodified heat-resistant pep-
tides (class II), heat-labile proteins (class III), and circular
bacteriocins (class IV) (references 10 and 26 and references
therein). Many LAB bacteriocins are inhibitory toward a wide
panel of Gram-positive bacteria, including relevant pathogen
and food spoilage bacteria. Therefore, a major effort has been
made in the last decades to understand their ecological role in
complex ecosystems (e.g., fermented foods and the gastroin-
testinal tract) and the molecular basis of their inhibitory activ-
ity for rationalizing their use as natural preservatives in food or
as promising anti-infectives (19, 23).
Although most LAB bacteriocins were shown to act as mem-
brane permeabilizers when added at high concentrations, it is
being recognized that bacteriocin killing is target mediated.
Many bacteriocins make use of receptors or docking molecules
present in the cell envelopes of susceptible strains prior to pore
formation. Nisin and many other structurally related lantibiot-
ics specifically bind to the cell wall precursor lipid II (5, 6).
Moreover, several class II bacteriocins, such as lactococcin A,
sakacin A, and enterocin P, form a complex with the mem-
brane component IIC of the mannose phosphoenolpyruvate
(PEP)-dependent phosphotransferase system (PTS) trans-
porter (16, 29).
Functional PTSs consist of two general proteins, enzyme I
(encoded by ptsI) and the heat-stable phosphocarrier protein
HPr (encoded by ptsH), and sugar-specific permeases or en-
zyme II complexes. The latter catalyze the translocation and
concomitant phosphorylation of several different sugars and
usually consist of three or four proteins or protein domains,
namely, IIA, IIB, IIC, and, when present, IID. Phosphoryl
relay proceeds sequentially from PEP to EI, HPr, IIA, IIB, and
the incoming sugar, which is transported across the membrane
via the IIC porter (15, 39). Expression of PTS-encoding genes
is tightly regulated, and that of genes encoding alternative
sugars is often subject to carbon catabolite repression (14).
Beyond the primary function of sugar transport, PTSs play
roles in various processes central to the physiology of the cell,
including a large number of mechanisms for metabolic and
transcriptional regulation (15). As described above, they also
play a role as receptors of some class II bacteriocins. In fact,
resistance to class II bacteriocins has been often linked to the
absence or repression of the genes coding for the mannose
PTS, which is involved in glucose uptake (11, 16, 22, 41).
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Therefore, one immediate consequence of class II bacteriocin
resistance is impaired growth on glucose, while utilization of
other sugars is favored (28, 48).
Based on the proposed use of LAB bacteriocins as food
preservatives and to provide large enough quantities for struc-
ture-function studies, several studies have focused on improv-
ing bacteriocin production and/or reducing production costs by
using by-products (reference 12 and references therein). En-
gineering of bacteriocin immunity has been proven to increase
nisin yields in Lactococcus lactis and in heterologous hosts (24,
46). Moreover, bacteriocin clusters have been suggested as a
food-grade alternative to antibiotic resistance markers (47). In
spite of this, little is known about the impact that synthesis of
bacteriocins may have on the physiology of the producing
strain. This issue is particularly relevant when bacteriocin pro-
duction is seen as a valuable technological trait and needs to be
transferred to industrial strains. Recently, Fallico et al. (18)
reported that conjugation of the plasmid pMRC01 carrying the
lacticin 3147 bacteriocin cassette imposed a metabolic burden
on several L. lactis starter strains.
In this work, we have studied the impact of plasmid pBL1,
encoding the bacteriocin lactococcin 972 (Lcn972), on L. lactis.
Lcn972 is an atypical 66-amino-acid (aa) nonmodified bacteri-
ocin synthesized by L. lactis IPLA972. It targets exclusively the
Lactococcus genus and thus far is the only nonlantibiotic that
binds to lipid II, inhibiting cell wall biosynthesis, without dis-
rupting membrane integrity (34, 36). The genes for the syn-
thetic machinery are carried on the 11-kbp plasmid pBL1
(GenBank accession number AF242367.1) and consist of a
structural gene and two other open reading frames (ORFs)
encoding a putative ABC transporter, which is presumably
involved in self-immunity. Introduction of pBL1 in L. lactis
rendered strains that were able to produce Lcn972 and that
were immune to it, without showing other particular traits (34,
36). In this study, however, genome-wide transcriptomics re-
vealed changes in the expression of genes directly related to
oligopeptide and sugar uptake. Bearing in mind the roles of
sugar PTSs in the mode of action of other bacteriocins and in
bacterial metabolism, we have characterized in more detail the
response of L. lactis to the presence of the bacteriocin-encod-
ing plasmid pBL1.
MATERIALS AND METHODS
Bacteria, plasmids, and culture conditions. The strains and plasmids used in
this study are listed in Table 1. Lactococcal strains were routinely grown in M17
(Oxoid) with glucose (0.5%, wt/vol; 27.5 mM) at 30°C (the optimal growth
temperature) or 37°C (when required for genetic manipulation). Escherichia coli
DH10B was used for intermediate cloning and grown on 2YT (44) at 37°C with
shaking. For physiological characterization, lactococcal cultures were grown stat-
ically and without pH control (initial pH, 6.5), at 30°C, in chemically defined
medium (CDM) containing 1% (wt/vol) glucose (55.5 mM) or cellobiose
(29.2 mM), in rubber-stoppered bottles, as described previously (8). Growth
was started by addition of a preculture (inoculum) in early stationary phase to an
initial optical density at 600 nm (OD600) of approximately 0.05. Precultures were
grown in glucose-CDM, except for adapted cells, for which the substrate was the
same as for the culture; all other conditions were as described above. When
necessary, erythromycin was used at a final concentration of 5 g ml1 and
ampicillin was used at 100 g ml1. Growth was monitored by measuring the
optical density at 600 nm. Growth rates () were calculated through linear
regressions of the plots of ln OD600 versus time during the exponential growth
phase. Growth rates and other growth parameters were analyzed using the Instat
software (GraphPad Software).
Transcriptome analysis. Genome-wide transcriptional experiments were per-
formed using DNA microarrays containing 2,457 annotated genes in the genome
of L. lactis MG1363 and were carried out essentially following the methods for
cell disruption, RNA isolation, RNA quality control, cDNA synthesis, indirect
labeling, hybridization, and scanning described previously (50). RNA from three
biological replicates was extracted from exponentially growing (OD600 of 0.4) L.
lactis MG1614 and MG1614.2 cultures in GM17 at 30°C. Data were processed as
described previously (37).
Construction of L. lactis MG1363 celB and pBL1E. Standard molecular
cloning techniques were followed as described elsewhere (44). Restriction en-
zymes were purchased from Takara (Otsu, Shiga, Japan) and T4 ligase from
Invitrogen (Barcelona, Spain). Oligonucleotides were supplied by Sigma (Ma-
drid, Spain) and are shown in Table 2. PCRs were carried out using PuRe Taq
Ready-to-Go PCR beads (GE Healthcare, Buckinghamshire, United Kingdom).
The celB-1 and celB-4 primers were used to amplify a 2.4-kbp chromosomal
fragment containing celB plus 0.9-kbp flanking regions. PCR conditions were as
follows: 95°C for 5 min (1 cycle); 95°C for 30 s, 60°C for 30 s, and 72°C for 1 min
(35 cycles); and 72°C for 10 min (1 cycle). The resulting amplicon was cloned in
TABLE 1. Strains and plasmids used in this study
Strain or plasmid Relevant phenotype or genotypea Reference(s)or source
Strains
L. lactis
MG1363 Plasmid-free derivative of NCDO712 20
MG1363/pBL1 MG1363 carrying pBL1, lcn972 Lcn972r This work
MG1363/pBL1E MG1363 carrying pBL1E, lcn972 Lcn972r Emr This work
MG1363 celB MG1363; chromosomal deletion of celB This work
MG1614 Strr Rifr derivative of MG1363 20
MG1614.2 MG1614 carrying pBL1 35
MG1363 celB/pBL1E MG1363 celB carrying pBL1E, Emr lcn972 Lcn972r This work
E. coli DH10B Plasmid free 21
Plasmids
pBL1 Lcn972-encoding plasmid, 10.9 kbp 35, 45
pBL1E erm from pNG8048 cloned in the unique EcoRV of pBL1_orf4 This work
pCR2.1 Cloning of PCR products, Apr Invitrogen
pCR::celB4-1 celB and flanking regions cloned in pCR2.1 This work
pCR::dcelB pCR::celB4-1 with a 1,019-bp deletion in celB This work
pGhost9 Thermosensitive, Emr 33
pGhost::dcelB Incomplete celB cloned in pGhost9 This work
a Str, streptomycin; Rif, rifampin; Em, erythromycin; Ap, ampicillin.
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the E. coli plasmid pCR2.1, generating pCR::celB4-1. This plasmid was HincII
digested and religated, generating pCR::dcelB, lacking a 1.0-kbp HincII internal
fragment. The incomplete celB gene plus flanking regions was released from
pCR::dcelB as a 1.4-kbp XbaI-SpeI fragment and subsequently cloned in the
thermosensitive L. lactis plasmid pGhost9 digested with SpeI to obtain
pGhost::dcelB. L. lactis MG1363 was transformed with pGhost::dcelB, and first
and second recombination events were followed essentially as previously de-
scribed (33). celB deletion was confirmed by PCR with appropriate primer pairs
and DNA sequencing.
To construct the recombinant plasmid pBL1E, the erythromycin resistance
gene erm was excised from pNG8048 (51) by SmaI-EcoRV restriction and ligated
to the unique EcoRV site present in pBL1_orf4. L. lactis MG1363/pBL1E trans-
formants were selected on GM17 with erythromycin at 5 g ml1.
RT-qPCR. RNA was extracted using the Illustra RNAspin Mini RNA isolation
kit (GE Healthcare), and the RNA concentration was determined by absorbance
at 260 nm. cDNA was generated with the iScript cDNA synthesis kit (Bio-Rad).
PCR amplification was performed in a 7500 Fast real-time PCR system (Applied
Biosystems, Warrington, United Kingdom). Primers used for reverse transcrip-
tase quantitative PCR (RT-qPCR) are listed in Table 2. Amplification was
carried out in 25 l containing either 0.01 or 0.002 g cDNA (according to the
expected expression levels), 1 Power SYBR green (Applied Biosystems), and
each primer at a concentration of 0.56 M. After incubation at 95°C for 10 min,
amplification proceeded with 40 cycles of 95°C for 15 s and 60°C for 1 min.
Standard curves were generated by plotting the cycle threshold (CT) values of
reactions performed on serial dilutions of cDNA against the logarithm of cDNA
concentrations. cDNA concentrations were correlated to quantify relative gene
expression levels. The housekeeping gene tuf, encoding the elongation factor Tu,
was used to normalize (43).
ELISA detection of Lcn972. The bacteriocin Lcn972 in culture supernatants
was quantified by a noncompetitive enzyme-linked immunoassay (NCI-ELISA)
with rabbit polyclonal antibodies against Lcn972 (1). Primary and secondary
antibodies were used at 1:1,000 and 1:40,000 dilutions, respectively. Pure Lcn972
(15 to 1 g/ml) was used as standard.
Lcn972 susceptibility tests. MICs were assayed by the broth microdilution
method in GM17 as described elsewhere (34). Dose-response curves were de-
termined in CDM in microtiter plates. Overnight cultures in CDM-glucose or
CDM-cellobiose were adjusted to an OD600 of 0.1, and 100 l was used to
inoculate wells containing Lcn972 from 9.6 to 0 g/ml. Growth was followed in
a microtiter reader (Bio-Rad) at 30°C until control cultures without Lcn972
reached an OD600 of 0.7 to 0.8, which was taken as 100% growth. For challenge
tests, exponentially growing cultures in CDM-cellobiose at an OD600 of 0.2 were
treated with Lcn972 at 0.1 M (5 times the MIC). Sodium phosphate buffer (50
mM, pH 6.8) was used as a control. Cultures were incubated for 1 h at 30°C, and
appropriate 10-fold dilutions were plated on GM17 agar plates for counting.
Survival (percent) was defined as CFU/ml in treated cultures divided by CFU/ml
in the control samples.
Quantification of fermentation products during growth. Samples (2 ml) were
taken at different growth stages, centrifuged (13,200 g, 5 min, 4°C), and filtered
(0.22 m), and the supernatant solutions were stored at 20°C until analysis by
high-performance liquid chromatography (HPLC). Substrate and fermentation
end products (lactate, acetate, ethanol, formate, acetoin, 2,3-butanediol, and
pyruvate) were quantified in an HPLC apparatus equipped with a refractive
index detector (Shodex RI-101; Showa Denko K. K., Japan) using an HPX-87H
anion-exchange column (Bio-Rad Laboratories Inc., Hercules, CA) at 60°C, with
5 mM H2SO4 as the elution fluid and a flow rate of 0.5 ml min1. Cellobiose was
similarly quantified in an ICSep ION-300 column preceded by an ICSep ICE-
GC-801 precolumn (Transgenomic, San Jose, CA), at 65°C and 0.4 ml min1 in
8.5 mM H2SO4, using a refractive index detector RI2414 (Waters, Milford, MA).
For the yield calculation, two time points, one immediately after inoculation
and the other at the time of growth arrest (T30, nonadapted cells), were con-
sidered. ATP production was calculated from the fermentation products, assum-
ing that all ATP was synthesized by substrate-level phosphorylation. The average
specific consumption rates of cellobiose were estimated from a first-order deriv-
ative of a polynomial fit of the observed substrate consumption time series.
Determination of intracellular metabolites during growth. Ethanol extracts
for analysis by 31P nuclear magnetic resonance (NMR) and quantification of
phosphorylated metabolites in MG1363/pBL1 and the control strain at the mid-
exponential growth phase were prepared as described elsewhere (42). The dried
extracts were dissolved in 2 ml of aqueous solution containing 5 mM EDTA and
12.5% (vol/vol) 2H2O (final pH of approximately 6.5). Assignment of resonances
and quantification of phosphorylated metabolites were based on previous studies
(38, 42) or done by spiking the NMR sample extracts with the suspected pure
compounds. Intracellular metabolite concentrations were calculated using a
value of 2.9 l mg of protein1 for the intracellular volume of L. lactis (40). The
reported values for intracellular phosphorylated compounds are averages from
two independent growth experiments, and the accuracy was around 15%.
Microarray data accession number. The DNA microarray data are available at
the Gene Expression Omnibus (GEO) repository under accession number
GSE30625.
RESULTS
Transcriptional analysis of L. lactis with the bacteriocin
Lcn972 plasmid pBL1. To gain a deeper insight into the impact
that the presence of the Lcn972-encoding plasmid pBL1 may
exert in L. lactis, a genome-wide transcriptional analysis was
carried out with L. lactis MG1614.2, carrying the bacteriocin
plasmid pBL1, compared to the parental strain L. lactis
MG1614 when growing under standard laboratory conditions
in GM17. A relatively discrete transcriptional response was
observed, with a total of 10 genes showing significantly (P 
0.001) changed expression of over a factor of two (Table 3).
Besides those coding for proteins of unknown function, up-
regulation of the lactococcal oligopeptide uptake system was
observed. oppA and oppB were clearly overexpressed, but other
members of the system (oppF, oppC, oppD, and the endopep-
tidase gene pepO) were also upregulated, although just below
the established cutoff levels (see data under GEO accession
number GSE30625). Overexpression of genes coding for pro-
teins involved in DNA rearrangement/mobilization was also
noted. This could be due to cross-hybridization with trans-
posase genes present in the composite plasmid pBL1. Indeed,
pBL1_orf9 shares 86% and 99% identity at the nucleotide level
with llmg0674_tnp1297 and llmg0717_tnp946, respectively, ac-
TABLE 2. Oligonucleotides used in this study
Primer Sequence (5 3 3)a Function
celB-qF1 ATTTGGCCCGTGCTTACG qRT-PCR, celB
celB-qR1 TTTGGCAAACCTGCAAATAGG
QptcC-F CGTGTTCGGTATTGCTTACG qRT-PCR, ptcC
QptcC-R TGTTAAACCAGCGGGTACTC
qBglS-F TACACCGCAGTATGCTAAGG qRT-PCR, bglS
qBglS-R TTGGCCGACTTCAAGAGTTC
Tuf-F GGTAGTTGTCGAAGAATGGAGTGTGA qRT-PCR, internal control
Tuf-R TAAACCAGGTTCAATCACTCCACACA
celB-1 AACTCtAGATGGCCTTTGTA (XbaI) Cloning and disruption of celB
celB-4 gAagAtctAAGACAGCCGCTCC (BglII)
a Changes introduced to generate restriction sites (underlined and shown in parentheses) are indicated in lowercase.
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cording to BLASTN (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
The same could have accounted for the hypothetical acetyl-
transferase gene llmg0676, to which pBL1_orf1 shows 99%
identity.
The cellobiose-specific PTS permease (IICCel domain) gene
celB and the upstream llmg0186 were the only genes down-
regulated in the presence of pBL1 (Table 3). llmg0186 codes
for a conserved hypothetical protein, also identified in L. lactis
IL1403 (ybhE), which might be functionally related to celB, as
the two genes seem to form a single transcriptional unit (3). An
absence of specific PTS permeases has been phenotypically
linked to resistance to several class II bacteriocins. Moreover,
PTSs are main players in bacterial metabolism mediating sugar
uptake, the main energy source in Lactococcus. Thus, we pro-
ceeded to further investigate celB repression in the presence of
pBL1.
Expression of cellobiose-related genes in the presence of
pBL1. It has been recently shown that point mutations, which
might be selected within very closely related L. lactis strains,
may have a pronounced effect on gene expression and, subse-
quently, on particular phenotypes. This has been exemplified
by comparative transcriptomics of L. lactis MG1363 and its
derivative L. lactis NZ9000, generated by the insertion of the
two-component system nisKR, which allows nisin-inducible
gene expression. Specific point mutations in the latter strain
accounted for altered expression of several genes involved in
carbohydrate metabolism, which translated into different
growth rates on specific sugars (31). The reference strain that
we used for the transcriptional analysis was L. lactis MG1614,
an antibiotic-resistant derivative of L. lactis MG1363 which is
poorly characterized and whose genome sequence is unknown
(20). To avoid possible interferences and to unequivocally con-
firm by RT-qPCR that repression of celB is a direct conse-
quence of the presence of pBL1, we transformed this plasmid
into L. lactis MG1363 (Table 1). As shown below (see Table 5),
L. lactis MG1363/pBL1 transformants were able to synthesize
Lcn972 and were resistant to it. Furthermore, we generated a
celB knockout mutant, MG1363 celB, to evaluate the conse-
quences of celB repression.
Initially, the celB operon structure was investigated by RT-
PCR. The genomic context of celB in MG1363 is similar to that
described in L. lactis IL1403 (3). celB is flanked upstream by
the conserved gene llmg0186 and downstream by two small
ORFs followed by bglS, potentially encoding a phospho-	-
glucosidase involved in cellobiose hydrolysis. The presence of
mRNA encompassing llmg0186 and celB in L. lactis MG1363
cells growing on cellobiose was confirmed (data not shown).
This result is in agreement with the codownregulation of both
genes noted in the transcriptomic analysis (Table 3). In
contrast, we failed to detect a putative celB-bglS mRNA by
RT-PCR.
The expression of cellobiose-related genes, i.e., celB, ptcC,
and bglS, in the presence of pBL1 was determined by RT-
qPCR (Table 4) using total RNA isolated from glucose- and
cellobiose-growing cultures in CDM. ptcC was also included as
a cellobiose/glucose IIC porter (8, 30). In the presence of
cellobiose, the three analyzed genes were induced in MG1363,
but celB showed the highest fold induction which supports its
role as a main cellobiose uptake system in L. lactis (Table 4).
Interestingly, loss of CelB (MG1363 celB) resulted in a higher
expression ratio of ptcC, possibly as a way to counteract the
lack of celB and facilitate cellobiose uptake. In contrast, induc-
tion of celB and bglS was inhibited 5-fold and that of ptcC
3-fold by the presence of pBL1, confirming the hypothesis
raised from the transcriptomic results that pBL1 downregu-
lates celB.
TABLE 3. Significant changes in gene expression induced by the presence of the Lcn972-encoding plasmid pBL1 in L. lactis
MG1614 cultures growing exponentially in GM17 broth
Gene Ratioa Bayesian Pb Annotationc
Upregulated
llmg0701_oppA 4.83 9.50E08 Oligopeptide-binding protein OppA
llmg1012 4.73 4.00E06 Putative ABC transporter substrate-binding protein
llmg0676 3.14 1.28E05 Hypothetical acetyltransferase
llmg0699_oppB 2.85 2.31E06 Peptide transport system permease protein OppB
llmg0642 2.41 5.22E05 Hypothetical protein
llmg0711_tnpR 2.40 5.13E04 DNA-invertase/resolvase
llmg2348 2.36 7.65E05 Hypothetical protein
llmg0674_tnp1297 2.03 3.28E06 Transposase for insertion sequence element IS1297
Downregulated
llmg0186 4.93 5.49E10 Conserved hypothetical protein
llmg0187_celB 4.59 4.53E04 Cellobiose-specific PTS system IIC component
a Genes whose expression changes over 2-fold in the presence of pBL1 are shown. Negative values indicate downregulation.
b Determined by the Cyber-t test (32).
c According to GenBank accession number AM406671.
TABLE 4. Expression ratios of cellobiose-related genes in
exponentially growing L. lactis MG1363, MG1363/pBL1,
and MG1363 celB grown in CDM-cellobiose relative
to growth in CDM-glucose, determined
by RT-qPCR
L. lactis strain
Expression ratio for target gene
ptcC celB bglS
MG1363 3.0 216.3 53.5
MG1363/pBL1 1.2 43.5 10.2
MG1363 celB 7.6 —a 16.7
a —, celB is not present in this strain.
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pBL1 impairs growth on cellobiose. Based on the differential
expression of cellobiose-related genes in the presence of pBL1,
we proceeded to determine possible effects on the catabolism
of relevant sugars. As celB encodes the cellobiose PTS porter,
cellobiose was an obvious choice to use as a carbon source in
physiological studies. Glucose was used as control sugar.
Small differences in growth, although not statistically signif-
icant (P 
 0.05), were observed for glucose-grown cells sub-
cultured in fresh glucose-CDM, as the growth rates of
MG1363/pBL1 and MG1363 celB were slightly reduced com-
pared to that of MG1363 (Fig. 1A). Similarly, pBL1 did not
affect the homolactic behavior of MG1363. In contrast, sub-
culturing glucose-grown cells in CDM supplemented with cel-
lobiose (i.e., nonadapted cells) resulted in major and very sig-
nificant (P  0.01) differences in the growth profiles. Cultures
of MG1363 and derivatives were characterized by long lag
phases, and exponential growth started only 18 to 19 h after
inoculation (Fig. 1B). This was not surprising, as this behavior
was already reported for L. lactis MG1363 (31). The growth
rate and the maximal biomass produced were substantially
lower for strains MG1363/pBL1 and MG1363 celB than for
the control strain. These remarkable differences led us to ex-
amine in greater detail the kinetics of substrate consumption
and fermentation product formation in nonadapted cells grow-
ing on cellobiose (Fig. 2). The three strains showed a mixed
acid fermentation profile, but the product distribution was
markedly different in the parent strain compared with the
strain carrying pBL1 or MG1363 celB. In the manipulated
strains, formate, acetate, and ethanol (2:1:1) were the major
products, while lactate accounted for less than 20% of the
FIG. 1. Growth profiles of L. lactis MG1363 and its isogenic strains MG1363/pBL1 and MG1363 celB on glucose or cellobiose. Cultures were
grown in CDM supplemented with 1% (wt/vol) sugar substrate at 30°C in rubber-stoppered bottles without pH control (initial pH of 6.5).
(A) Preculture and culture grown on glucose. (B) Preculture grown on glucose and culture grown on cellobiose (nonadapted cells). (C) Preculture
and culture grown on cellobiose (adapted cells). The growth rate (), maximal OD600, and percentage of lactate (% Lct) at an OD600 of 0.7 to 0.9
formed from the substrate consumed are also shown for each condition tested. Growth curves are from a representative experiment. Growth was
repeated at least twice, and the values are averages for each condition.
FIG. 2. Substrate consumption and end product profiles during the fermentation of cellobiose (1%, wt/vol) by nonadapted L. lactis cells. Strains
MG1363 (A), MG1363/pBL1 (B), and MG1363 celB (C) were grown overnight in CDM supplemented with glucose (1%, wt/vol) and subcultured
in fresh medium containing cellobiose (1%, wt/vol) as for Fig. 1B. Supernatants obtained at different growth stages were analyzed by HPLC as
described in Materials and Methods. The values are averages from at least two independent experiments, and the average accuracy was 5%.
Symbols: diamonds, cellobiose; white bars, lactate; light gray bars, formate; medium gray bars, acetate; dark gray bars, ethanol; black bars, acetoin
plus 2,3-butanediol.
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substrate consumed. In contrast, lactate was the main product
from cellobiose metabolism in L. lactis MG1363, and curiously,
its yield increased dramatically during growth, from 0.4 at
mid-exponential phase (T24) to 1.3 in late stationary phase
(T42). At the time of growth arrest (T30), MG1363 had con-
sumed about 50% of the initial substrate, whereas MG1363/
pBL1 and MG1363 celB used only 30% of the cellobiose in
the medium. The biomass yield was, however, similar in
MG1363 and the celB mutant (about 17 g mol1 of substrate)
and slightly lower in the presence of pBL1 (about 16.2 g mol1
of substrate), correlating well with the OD600 values deter-
mined (Fig. 1B). In view of these data, it is reasonable to
speculate that the observed differences in growth rate and
maximal biomass in MG1363 compared to MG1363/pBL1 and
MG1363 celB are directly associated with cellobiose trans-
port. In line with this, the average cellobiose consumption rate
during exponential growth was higher in MG1363 (3.6 mmol
g1 h1) than in the presence of pBL1 (2.1 mmol g1 h1) or
in the absence of celB (2.3 mmol g1 h1).
This view was further supported by the growth profiles ob-
tained for adapted cells, i.e., early-stationary-phase cellobiose-
grown precultures subcultured in CDM-cellobiose (Fig. 1C).
Adaptation abolished the long lag phases (maximal growth
after 1 h at 30°C) and resulted in improved growth rates (20 to
35% increase) for all strains. Nevertheless, both the maximal
biomass produced and the growth rate were still considerably
higher in strain MG1363 than in MG1363/pBL1 or MG1363
celB. Adaptation also promoted the formation of lactate in
either the presence or absence of pBL1 in MG1363 (Fig. 1C).
pBL1 changes the intracellular dynamics of phosphorylated
metabolites. Prompted by the notable effect of pBL1 on the
growth properties and end product profiles of MG1363, we
asked whether intracellular metabolite levels would also be
affected by the plasmid during growth on cellobiose. Glucose
was used as a control condition. As expected, pBL1 had no
effect on the pool sizes of glycolytic intermediates (Fig. 3A) or
sugar-nucleotides (Fig. 3C) during growth on glucose as deter-
mined by 31P NMR in cell extracts. Contrastingly, pBL1 pro-
moted substantial changes in intracellular pool sizes in cello-
biose-growing cells. Fructose-1,6-bisphosphate (FBP), the
major mid-exponential-phase glycolytic intermediate in glu-
cose-growing cells and in cellobiose-growing MG1363, was re-
duced by about 2-fold (Fig. 3A). A similar effect was observed
for other upper glycolytic metabolites (dihydroxyacetone phos-
FIG. 3. Effect of pBL1 on intracellular phosphorylated metabolites during growth on glucose or cellobiose. Phosphorylated metabolites were
measured by 31P NMR in ethanol extracts of adapted MG1363 and MG1363/pBL1 cells (the same sugar substrate was used in precultures and
cultures) grown to mid-exponential phase in CDM supplemented with 1% (wt/vol) glucose (A and C) or cellobiose (B and D). Glycolytic
metabolites (A and B) and UDP-activated metabolites (C and D) are depicted. The average accuracy was 15%. Symbols: dark gray bars,
MG1363; white bars, MG1363/pBL1. DHAP, dihydroxyacetone phosphate; G6P, glucose-6-phosphate; FBP, fructose-1,6-biphosphate; 3PGA,
3-phosphoglycerate; 2PGA, 2-phosphoglycerate; PEP, phosphoenolpyruvate; Cel6P, cellobiose-6-phosphate; Gal, galactose; Glc, glucose; GlcNAc,
N-acetylglucosamine; MurNAc, N-acetylmuramic acid; pPep, pentapeptide; PRPP, 5-phosphorylribose 1-pyrophosphate.
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phate [DHAP] and glucose-6-phosphate [G6P]). The concen-
tration of cellobiose-6-phosphate, the product of the transport
step, was also 2-fold lower in the presence of pBL1. On the
other hand, the lower glycolytic metabolites 3-phosphoglycer-
ate (3-PGA), 2-PGA, and PEP showed increased concentra-
tions.
Of note was the drastic effect of pBL1 on the concentration of
the cell wall cytoplasmic precursors, UDP-N-acetylmuramoyl-
pentapeptide (UDP-MurNAc-pPep) and UDP-N-acetyl muramic
acid (UDP-MurNAc) (Fig. 3D). The latter accumulated only in
cellobiose-growing MG1363/pBL1, while UDP-MurNAc-pPep
increased by about 14-fold in this strain. In contrast, the level of
the other peptidoglycan cytoplasmic precursor, UDP-N-acetyl-
glucosamine (UDP-GlcNAc), was slightly lower, as were those of
all other UDP-activated sugars detected and 5-phosphorylribose
1-pyrophosphate.
Contribution of impaired growth on cellobiose to produc-
tion of and resistance to Lcn972. According to the physiolog-
ical data, the presence of pBL1 correlated well with defective
growth of L. lactis on cellobiose in a fashion similar to that for
a nonfunctional celB. Since the main phenotype that could be
attributed to pBL1 is the production of the bacteriocin Lcn972
(35, 45), we attempted to establish if there was a link between
Lcn972 synthesis or immunity and impaired growth on cello-
biose.
We determined Lcn972 production in supernatants from L.
lactis MG1363/pBL1 grown on glucose (i.e., low celB expres-
sion) or cellobiose (i.e., high celB expression) and in the celB
background, where celB is not present. In this case, we had to
make use of pBL1E, in which the erythromycin resistance
marker was cloned in the unique EcoRV site of pBL1, disrupt-
ing pBL1_orf4, because we were unable to recover any L. lactis
celB/pBL1 transformants by Lcn972 selection. Supernatant
samples were taken at the transition toward the stationary
phase (OD600s of 2.8 and 1.6 in glucose and cellobiose cultures,
respectively). As shown in Table 5, the mutation in pBL1E did
not affect production of Lcn972, as yields similar to those with
the wild-type plasmid pBL1 were detected (Table 5). No large
differences in Lcn972 production were observed when the
strains were growing in glucose. On the contrary, in cellobiose-
growing cultures, yields were somewhat higher in the celB
background, sustaining the idea that cells lacking this gene may
support higher Lcn972 production levels.
Next, we hypothesized that CelB may act as a putative re-
ceptor to facilitate Lcn972 antimicrobial activity and, conse-
quently, that producer cells would have a tendency to suppress
gene expression. According to MIC values in GM17, L. lactis
MG1363 and MG1363 celB were equally susceptible to
Lcn972 (MIC  0.15 g/ml). Moreover, dose-response curves
with increasing Lcn972 concentrations were essentially identi-
cal for L. lactis MG1363 and MG1363 celB regardless of
whether cultures were grown on glucose or cellobiose (Fig.
4A). In this light, in contrast to the mannose PTS, which is
targeted by several class II bacteriocins and determines bacte-
riocin activity, CelB is unlikely to be an essential receptor for
Lcn972. Interestingly, both the wild-type and celB strains
were somewhat more susceptible to Lcn972 when growing on
cellobiose than when growing on glucose (Fig. 4A). Therefore,
we asked whether repression of celB and the subsequent met-
abolic changes could make lactococcal cells able to cope better
with the presence of Lcn972, a scenario that Lcn972-producing
cells have to face. To test this, early-exponential-phase cello-
biose-growing (OD600  0.2) nonadapted L. lactis MG1363
and MG1363 celB cells were challenged with Lcn972 and
survival was scored (Fig. 4B). The highest percentage of sur-
FIG. 4. Susceptibility of L. lactis strains to Lcn972. (A) Dose-re-
sponse curves of L. lactis MG1363 (squares) and L. lactis MG1363
celB (triangles) with increasing Lcn972 concentrations growing in
CDM-glucose (closed symbols) and CDM-cellobiose (open symbols)
at 30°C in a microtiter plate. Growth in the absence of Lcn972 was
taken as 100% as monitored by OD600. Results are mean values for
triplicate wells, and standard deviations never exceeded 10% of the
given value. (B) Survival of L. lactis MG1363 celB and L. lactis
MG1363 nonadapted and adapted to cellobiose. Exponentially grow-
ing cells on cellobiose (OD600  0.2) were treated with 0.1 M Lcn972
for 1 h at 30°C before appropriate dilutions were plated on GM17.
Percent survival was defined as CFU/ml of treated cultures divided by
CFU/ml of control cultures.
TABLE 5. Production of Lcn972 by L. lactis strains in
CDM-glucose and CDM-cellobiose
L. lactis strain
Lcn972 production (g/OD unit)a in:
CDM-glucose CDM-cellobiose
MG1363/pBL1 5.4  0.0 A 6.6  0.0 A
MG1363/pBL1E 4.7  0.1 AB 6.9  0.1 A
MG1363 celB/pBL1E 4.4  0.3 B 11.1  1.1 B
a Samples were taken at the transition to stationary phase. Lcn972 was quan-
tified by ELISA using rabbit polyclonal Lcn972 antibodies and corrected by
OD600. Means and standard deviations for two independent cultures are shown.
Letters indicate significant differences (P  0.05) between strains growing in the
same medium.
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viving cells was found for L. lactis celB compared to the
wild-type L. lactis MG1363. Moreover, resistance to Lcn972
decreased further when L. lactis MG1363 had been previously
subcultured in CDM-cellobiose for 30 generations (adapted
cells) prior to the treatment. In this case, only 0.8% of the cells
survived (Fig. 4B). These results sustain the hypothesis that
downregulation of celB somehow triggers a defense mecha-
nism against the antimicrobial activity of Lcn972. Further-
more, it was also confirmed by RT-qPCR that celB RNA levels
in L. lactis MG1363 cellobiose-adapted cells were 6.4 times
higher than those in nonadapted cells when growing on glucose
(data not shown). This suggests that adaptation to cellobiose in
L. lactis MG1363 may imply increased basal expression of celB
in the presence of glucose.
DISCUSSION
The plasmid pBL1 had been previously shown to encode the
production of and immunity to the bacteriocin Lcn972 (35, 45).
This plasmid could be transferred into the susceptible L. lactis
MG1614, conferring to the new transformants the ability to
produce Lcn972 while any other obvious phenotype remained
elusive under standard laboratory conditions (35). However,
the genome-wide transcriptional analysis carried out in this
work revealed unexpected changes in gene expression that
suggested that bacteriocin synthesis is not gratuitous for pro-
ducing cells and may impose a metabolic burden.
Although we have not further investigated this, it seems
reasonable to speculate that the overexpression of genes in-
volved in oligopeptide transport in the presence of pBL1 re-
sponds to a higher nitrogen demand needed for Lcn972 bio-
synthesis. L. lactis is auxotrophic for multiple amino acids and
depends on its proteolytic system and peptide uptake for
growth. Moreover, the opp operon is highly repressed by the
presence of peptides in the growth medium via the pleiotropic
transcriptional repressor CodY, which senses the intracellular
pool of branched-chain amino acids (BCAAs), which are core-
pressors of CodY (references 13 and 17 and references
therein). The intracellular amino acid content in Lcn972-pro-
ducing cultures would presumably be lower, relieving opp from
CodY repression.
Another response to the presence of pBL1 deduced from
the microarray data was repression of llmg0186 and celB in-
volved in cellobiose metabolism. This PTS has been more
deeply characterized in L. lactis IL1403, but our results showed
that the structural organization is similar and that the two
genes form an operon also in L. lactis MG1363. The specific
downregulation of celB by pBL1 was further confirmed by
transforming this plasmid into L. lactis MG1363 and demon-
strating by RT-qPCR that celB RNA levels were lower in the
presence of pBL1. In this way, the possibility of strain-to-strain
variation based on nonidentified mutations prompted by the
plasmid was discarded. Moreover, although to a lesser extent,
induction of the other cellobiose transporter gene, ptcC, was
also inhibited by the presence of pBL1, supporting the notion
that cellobiose metabolism was specifically targeted by pBL1.
It is worth mentioning that celB RNA levels were almost iden-
tical in cells growing on glucose regardless of the presence of
pBL1 (expression ratio of 1.2 in MG1363 versus pBL1). This
observation is not in agreement with the initial transcriptomic
analysis carried out with cultures grown on glucose in the
complex medium M17. In L. lactis IL1403, induction of celB
requires the presence of cellobiose (3). Residual dextrins pres-
ent in the formulation of M17 may be enough to induce celB
expression in the control cells, thereby making more evident
the repression posed by pBL1.
The genetic evidence that cellobiose uptake was hindered in
Lcn972-producing cells was further supported by the subse-
quent physiological studies. All the results are in agreement
with a constrained sugar uptake based on the lower growth rate
in CDM-cellobiose, the more pronounced mixed acid fermen-
tation profile, and the lower substrate consumption rate ob-
served in L. lactis MG1363/pBL1. Moreover, these variables
paralleled those defined for the celB-defective strain. This view
was further supported by the differences found in the pool of
internal metabolites. Overall, the pool sizes of glycolytic me-
tabolites reflect a constriction in cellobiose utilization, which
most likely arises from the transport step limitation, and are in
accordance with previous studies on mutants lacking particular
sugar PTSs (8).
The lower pool sizes of UDP-activated sugars and/or amino
sugars might reflect rerouting of carbon flux to the production
of structural or storage polysaccharides in the presence of
pBL1. Moreover, since the lipid carrier C-55 is used both for
exocellular polysaccharide biosynthesis and for peptidoglycan
biosynthesis, a higher demand for the former would lead to the
accumulation of cell wall precursors, as previously described
(42). Lcn972 itself could also contribute, as it is a cell wall-
active bacteriocin that binds to lipid II, precluding its incorpo-
ration into preexisting peptidoglycan (34). Recently, it has
been shown that L. lactis MG1363 is able to synthesize a cell
wall polysaccharide pellicle that acts as a protective barrier (9).
Curiously, dense cell suspensions of MG1363/pBL1 were con-
siderably slimier than those of MG1363 (data not shown).
Whether pBL1 induces the synthesis of this protective pellicle
is under investigation.
For some bacteriocins, it has been shown that engineering of
bacteriocin immunity leads to higher bacteriocin production
yields (25, 27), showing that self-toxicity poses a burden to
increase bacteriocin productivity. Moreover, downregulation
of key enzymes involved in sugar metabolism has been shown
to be involved in tolerance to antibiotics (4). On this back-
ground, the observed metabolic response of L. lactis to the
presence of pBL1 suggests that pBL1-carrying cells seem to
mount a response to counteract the antimicrobial activity of
Lcn972, even in the presence of the putative immune system,
and signaling might occur via downregulation of celB. In favor
of this hypothesis are the facts that (i) slightly higher Lcn972
yields were obtained in a celB background, (ii) susceptibility
of L. lactis to Lcn972 increases when growth is on cellobiose,
and (iii) L. lactis celB is more tolerant than the wild type.
Moreover, celB is also downregulated in L. lactis strains that
are resistant to the bacteriocin Lcn972 (our unpublished re-
sults), supporting its role in self-protection against Lcn972. On
the other hand, CelB itself might also play a role as a docking
molecule to facilitate access of Lcn972 to its target lipid II.
However, in contrast to the case for the mannose PTSs which
are targeted by class II bacteriocins (16, 22, 29, 41), CelB seems
to be dispensable because L. lactis celB is still susceptible to
Lcn972.
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Beyond the significance of tuning celB expression as a trigger
to increase tolerance of L. lactis MG1363 to Lcn972, our re-
sults have also added some hints on cellobiose metabolism in
this strain which support future research on this particular
PTS. First, celB seems to be the main cellobiose transporter in
this strain, as it is highly induced in cellobiose-growing cultures
and at levels more than 70 times higher than those for ptcC.
Moreover, coregulation of bglS, demonstrated by both induc-
tion by cellobiose and a similar inhibition rate posed by pBL1,
supports its role as the putative phospho-	-glucosidase respon-
sible for cleavage of cellobiose-6-phosphate, as described for
IL1403 (2). Our data are also in agreement with a recent report
showing that rapid growth of L. lactis MG1363 on cellobiose is
preceded by the induction of cellobiose-specific genes (31). In
this regard, our results showed that adaptation seems to rely on
the higher basal expression levels of the llmg0186-celB operon,
and once the cells were grown on cellobiose, the initial lag
phase was no longer observed. The underlying molecular
mechanism remains to be clarified.
In many references in the literature, altered carbon metab-
olism has been linked to class IIa bacteriocin resistance (7, 28,
48, 49). However, some other practical consequences for the
field of bacteriocin production stem from the results of this
work. In the case of the bacteriocin Lcn972, a choice of inex-
pensive or renewable sources rich in dextrins or cellobiose as
substrates should be avoided, as a lower cell biomass will be
reached. Furthermore, celB has been shown to be involved in
lactose uptake by L. lactis lacking a lactose-specific PTS (3),
meaning that Lcn972 production by the recombinant L. lactis
MG1363/pBL1 would be seriously compromised in milk or
dairy products where lactose is the main available carbohy-
drate.
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